Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Department of Justice
Argus Health
Chubb
Cipla
Fuji
Queensland Health
McKinsey
Teva

Generated: June 25, 2018

DrugPatentWatch Database Preview

NAPHCON FORTE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Naphcon Forte, and what generic alternatives are available?

Naphcon Forte is a drug marketed by Alcon and is included in one NDA.

The generic ingredient in NAPHCON FORTE is naphazoline hydrochloride. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride profile page.
Summary for NAPHCON FORTE
Drug patent expirations by year for NAPHCON FORTE
Medical Subject Heading (MeSH) Categories for NAPHCON FORTE
Synonyms for NAPHCON FORTE
1H-Imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-, monohydrochloride
1H-Imidazole,5-dihydro-2-(1-naphthalenylmethyl)-, monohydrochloride
2-(1-Naphthylmethyl)-2-Imidazoline Hydro- Chloride
2-(1-Naphthylmethyl)-2-imidazoline hydrochloride
2-(1-Naphthylmethyl)-2-imidazoline monohydrochloride
2-(1-naphthylmethyl)-4,5-dihydro-1H-imidazole hydrochloride
2-(1-Naphthylmethyl)imidazoline hydrochloride
2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole hydrochloride
2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride
2-(naphthylmethyl)-2-imidazoline, chloride
2-IMIDAZOLINE HYDROCHLORIDE
2-Imidazoline, 2-(1-naphthylmethyl)-, monohydrochloride
2-Imidazoline, monohydrochloride
35412-62-5
4,5-Dihydro-2-(1-naphthylmethyl)-1H-imidazole Hydrochloride
550-99-2
835-31-4 (Parent)
AB2000621
AC1L1WKK
AC1LCWB1
AKOS015908797
Albacon
Albalon
Albalon (TN)
Albalon Liquifilm
AN-15699
AOB5340
AS-16861
BB_SC-2388
BG0263
C-15060
C07898
C14H14N2.HCl
CCG-40122
CHEBI:7470
CHEMBL1706
Clear Eyes
Clera hydrochloride
Coldan
Comfort Eye Drops
component of Nasocon
CPD000058292
CS-2555
CTK5J7411
D00743
Degest-2
DJDFFEBSKJCGHC-UHFFFAOYSA-N
EINECS 208-989-2
FT-0603466
HE185790
HMS1568I13
HMS1920P11
HSDB 2174
HY-B0446
I14-3428
LS-175633
LS-79667
LT00114215
LT00233108
MFCD00012554
MLS000028434
MLS001148448
MLS002222217
MolPort-000-703-064
MolPort-002-904-680
MZ1131787D
N0542
NAFAZAIR
Naphazoline (hydrochloride)
Naphazoline chloride
NAPHAZOLINE HCL
NAPHAZOLINE HYDROCHLORIDE
Naphazoline hydrochloride (JP17/USP)
Naphazoline hydrochloride (Naphcon)
Naphazoline hydrochloride [JAN]
Naphazoline hydrochloride [USP:JAN]
Naphazoline hydrochloride BP98 USP24
Naphazoline hydrochloride, European Pharmacopoeia (EP) Reference Standard
Naphazoline hydrochloride, United States Pharmacopeia (USP) Reference Standard
Naphazolini chloridum
Naphazoliniumchlorid
Naphcon
Naphcon;Albalon
Naphthasolium chloride
Naphthylmethylimidazolinhydrochlorid
NC00523
NCGC00094732-01
NCGC00094732-02
NCGC00094732-03
NCGC00094732-04
Niazol
NSC 35711
NSC-35711
NSC-757110
NSC35711
NSC757110
Opcon
Opera_ID_230
Pharmakon1600-01500424
Prestwick_507
Privine hydrochloride
Prizole hydrochloride
Rhinantin
Rhinoperd
Rinofug
s2519
SAM002554916
Sanorin
SBB017549
SC-46390
SCHEMBL24153
SMR000058292
SPECTRUM1500424
ST50319852
Stricylon
SureCN1649580
TR-019439
UNII-MZ1131787D
Vasoclear
Vasocon
Vasocon (TN)
W-105587
WLN: L66J B1- BT5M CN BUTJ &GH

US Patents and Regulatory Information for NAPHCON FORTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon NAPHCON FORTE naphazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 080229-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Dow
Federal Trade Commission
Accenture
Fish and Richardson
Argus Health
Julphar
Citi
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.